Prognosis value of cardiac biomarkers in transthyretin deposition cardiac amyloidosis in real life

20 May 2023 (08:00 - 20:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

6 More presentations in this session

Presentation thumbnail

How to differentiate pneumonia from heart failure in patients with simultaneously reported pneumonia or pulmonary edema in the radiologic findings of chest computed tomography

Doctor K. Kim (Jinju, KR)

Abstract Slides

Presentation thumbnail

NT-proBNP levels in diabetic cardiomyopathy: results from the ARISE-HF trial

Doctor N. Ibrahim (Boston, US) Professor J. Januzzi (Boston, US)

Abstract Slides

Presentation thumbnail

Using a targeted proteomics chip to explore differences in pathophysiological pathways between normal weight versus overweight/obese heart failure patients

Doctor J. Korduner (Lund, SE)

Abstract Slides

Presentation thumbnail

Association between triglyceride with all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong

Mrs Q. Ren (Hong Kong, HK)

Abstract Slides

Presentation thumbnail

Concentrations of NT-proBNP across pulmonary hypertension groups

Doctor P. Costa (Genoa, IT)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart Failure - biomarkers 3

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Session

From genetic signatures to clinical implications

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources